CVS Health alza stima utile rettificato 2026 ad almeno 8,2 dollari per azione
CVS Health alza stima utile rettificato 2026 ad almeno 8,2 dollari per azione CVS Health alza la
Related stories
Nooks Secures $500M and Launches AI Sales Assistant Node
M impact | EQUITY | Nov 04, 2026, 02:10 PM UTC
Comscore Reports Q3 Revenue Down 14.3%, Targets $20M–$25M Cost Savings
Comscore reported third-quarter 2026 revenue of $76.2 million, down 14.3% year over year. Net loss was $65.5 million, including a $57.3 million non-cash goodwill impairment and $5.
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC
Sherritt to Temporarily Lay Off About 280 Canadian Employees
Sherritt says the layoffs will affect 47% of its Canadian workforce and last about 90 days as it works to preserve liquidity and restore refining operations in Fort Saskatchewan, A
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC
JELD-WEN Reports Third-Quarter 2026 Revenue of $798.5 Million
Net revenues fell 1.4% year over year to $798.5 million. The company posted a $17.2 million net loss, compared with a $367.6 million loss a year earlier, and maintained its 2026 re
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC
Latham Group Reports Q3 Results, Announces $100 Million Buyback
Latham Group reported third-quarter net sales of $182.2 million, up 12.5% year over year, net income of $12.1 million and Adjusted EBITDA of $45.3 million, up 18.1%. It approved a
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC
EagleRock Land Reports Q3 Results and Updates 2026 EBITDA Guidance
EagleRock Land reported third-quarter revenue of $43.3 million, net income of $11.3 million, Adjusted EBITDA of $34.0 million and free cash flow of $31.8 million. It updated full-y
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC